The first is misleading ads.
Concern about possible cardiovascular problems associated with Vioxx, however, soon arose.
By contrast, Vioxx made $2.5 billion for Merck last year.
Celebrex and Vioxx have become household names in recent years.
Vioxx was easier on the stomach than aspirin, but it cost more.
The last days of Vioxx began with FedEx deliveries on Sept. 14.
Many doctors and patients liked Vioxx's track record on gastrointestinal problems, a major source of worry for arthritis patients.
The company was already facing two class action lawsuits alleging patient harm from Vioxx.
The FDA's own study of the Vioxx safety issue has become mired in controversy.
